Nicole Leber | Investor Relations Associate |
Panna Sharma | Chief Executive Officer and President |
David Margrave | Chief Financial Officer and Secretary |
Kishor Bhatia | Chief Scientific Officer |
John Vandermosten | Zacks Research |
Michael King | EF Hutton |
Welcome to our fourth quarter and full-year 2022 earnings call. I will be your host for today's call.
As a reminder, this call is being recorded and all attendees are in a listen-only mode.
We will open up the call for questions and answers after management's presentation. A webcast replay of today's conference call will be available on our website at lanternpharma.com after the call.